The emerging role of RNA N6-methyladenosine methylation in breast cancer

被引:0
|
作者
Fangchao Zheng
Feng Du
Jiuda Zhao
Xue Wang
Yiran Si
Peng Jin
Haili Qian
Binghe Xu
Peng Yuan
机构
[1] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Medical Oncology, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital
[2] Peking University Cancer Hospital and Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), The VIPII Gastrointestinal Cancer Division of Medical Department
[3] Affiliated Hospital of Qinghai University & Affiliated Cancer Hospital of Qinghai University,Breast Disease Diagnosis and Treatment Center
[4] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of VIP Medical Services, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital
[5] Chinese Academy of Medical Sciences and Peking Union Medical College,Department of Surgery, National Cancer Centre/National Clinical Research Center for Cancer/Cancer Hospital
[6] Chinese Academy of Medical Sciences and Peking Union Medical College,State Key Laboratory of Molecular Oncology, Cancer Hospital/Institute
来源
Biomarker Research | / 9卷
关键词
RNA methylation; Breast cancer; Clinicopathological features; Prognosis; Drug target;
D O I
暂无
中图分类号
学科分类号
摘要
N6-methyladenosine (m6A) modification is the most prevalent internal mRNA modification and is involved in many biological processes in eukaryotes. Accumulating evidence has demonstrated that m6A may play either a promoting or suppressing role in breast cancer, including in tumorigenesis, metastasis and angiogenesis. In this review, we summarize the latest research progress on the biological function and prognostic value of m6A modification in breast cancer, as well as potential related therapeutic strategies.
引用
收藏
相关论文
共 50 条
  • [1] The emerging role of RNA N6-methyladenosine methylation in breast cancer
    Zheng, Fangchao
    Du, Feng
    Zhao, Jiuda
    Wang, Xue
    Si, Yiran
    Jin, Peng
    Qian, Haili
    Xu, Binghe
    Yuan, Peng
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [2] The Emerging Role of N6-Methyladenosine RNA Methylation as Regulators in Cancer Therapy and Drug Resistance
    Chen, Zhaolin
    Hu, Ying
    Jin, Le
    Yang, Fan
    Ding, Haiwen
    Zhang, Lei
    Li, Lili
    Pan, Tingting
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [3] The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
    Hu, Xiaoge
    Lei, Xiangxiang
    Guo, Jinhui
    Fu, Wen
    Sun, Wen
    Lu, Qiliang
    Su, Wei
    Xu, Qiuran
    Tu, Kangsheng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] The emerging roles of N6-methyladenosine RNA methylation in human cancers
    Huafei Shen
    Yifen Lan
    Yanchun Zhao
    Yuanfei Shi
    Jie Jin
    Wanzhuo Xie
    Biomarker Research, 8
  • [5] The emerging roles of N6-methyladenosine RNA methylation in human cancers
    Shen, Huafei
    Lan, Yifen
    Zhao, Yanchun
    Shi, Yuanfei
    Jin, Jie
    Xie, Wanzhuo
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [6] N6-Methyladenosine methylation modification in breast cancer: current insights
    Zhang, Guangwen
    Cheng, Chen
    Wang, Xinle
    Wang, Shiming
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [7] Role of N6-methyladenosine RNA modification in cancer
    Qu, Yi
    Gao, Nannan
    Zhang, Shengwei
    Gao, Limin
    He, Bing
    Wang, Chao
    Gong, Chunli
    Shi, Qiuyue
    Li, Zhibin
    Yang, Shiming
    Xiao, Yufeng
    MEDCOMM, 2024, 5 (09):
  • [8] The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
    Xiaoxin Xu
    Jiayao Zhao
    Mingyue Yang
    Lutuo Han
    Xingxing Yuan
    Wencheng Chi
    Jiakang Jiang
    European Journal of Medical Research, 28
  • [9] RNA N6-methyladenosine methylation and skin diseases
    Yu, Yaqin
    Lu, Shuang
    Jin, Hui
    Zhu, Huan
    Wei, Xingyu
    Zhou, Tian
    Zhao, Ming
    AUTOIMMUNITY, 2023, 56 (01)
  • [10] The emerging roles of N6-methyladenosine RNA modifications in thyroid cancer
    Xu, Xiaoxin
    Zhao, Jiayao
    Yang, Mingyue
    Han, Lutuo
    Yuan, Xingxing
    Chi, Wencheng
    Jiang, Jiakang
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)